Boryung Corporation

KOSE:A003850 Stock Report

Market Cap: ₩699.5b

Boryung Balance Sheet Health

Financial Health criteria checks 6/6

Boryung has a total shareholder equity of ₩599.1B and total debt of ₩182.4B, which brings its debt-to-equity ratio to 30.4%. Its total assets and total liabilities are ₩1,009.3B and ₩410.3B respectively. Boryung's EBIT is ₩70.1B making its interest coverage ratio 8.2. It has cash and short-term investments of ₩27.9B.

Key information

30.4%

Debt to equity ratio

₩182.38b

Debt

Interest coverage ratio8.2x
Cash₩27.89b
Equity₩599.06b
Total liabilities₩410.27b
Total assets₩1.01t

Recent financial health updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Sep 20
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Recent updates

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Sep 20
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Aug 05
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Apr 06
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Apr 28
A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Feb 27
Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09
Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25
Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23
Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Financial Position Analysis

Short Term Liabilities: A003850's short term assets (₩478.8B) exceed its short term liabilities (₩265.3B).

Long Term Liabilities: A003850's short term assets (₩478.8B) exceed its long term liabilities (₩144.9B).

Debt to Equity History and Analysis

Debt Level: A003850's net debt to equity ratio (25.8%) is considered satisfactory.

Reducing Debt: A003850's debt to equity ratio has reduced from 33.8% to 30.4% over the past 5 years.

Debt Coverage: A003850's debt is well covered by operating cash flow (43.8%).

Interest Coverage: A003850's interest payments on its debt are well covered by EBIT (8.2x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 08:03
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boryung Corporation is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Myung Sun LeeDB Financial Investment Co. Ltd.
Hyung Soo KimHanwha Investment & Securities Co., Ltd.